Onconic Therapeutics (476060.KQ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenKRW 15,360.00

From 52W high−58.00%

Volume166131.00

Market capKRW 678.44B

P/E (TTM)27.8x

P/S (TTM)8.3x

Div yield—

Key dataSep 18, 2026

Open

KRW 15,360.00

From 52W high

−58.00%

Volume

166131.00

Market cap

KRW 678.44B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

32.5x

P/E (TTM)

27.8x

RSI (14)

48.4

MomentumView details →

1D Return

+3.56%

YTD Return

−23.99%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

27.8x

EV/EBITDA

32.5x

EV/Sales

7.5x

P/S (TTM)

8.3x

P/B (TTM)

7.9x

ProfitabilityView details →

Gross Margin

54.42%

Net Margin

29.51%

EBITDA Margin

23.07%

ROE (TTM)

28.27%

ROA (TTM)

26.08%

Asset Turnover

0.91x

GrowthView details →

Revenue YoY

+179.26%

EPS YoY

+70.10%

FCF YoY

+488.96%

Revenue CAGR 3Y

+725.25%

EPS CAGR 3Y

+11.02%

EBITDA YoY

+575.13%

MomentumView details →

1D Return

+3.56%

YTD Return

−23.99%

1Y Return

+31.80%

RSI (14)

48.4

vs 50D SMA

+7.37%

vs 200D SMA

−17.57%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

11.39x

Quick Ratio

11.39x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

KRW 83.12

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

KRW 0.00

Avg Surprise (4Q)

—

Rev Surprise

−9.08%

Financials snapshotView financials →

Revenue (TTM)

82.17B

Net Income (TTM)

24.25B

Op. CF (TTM)

16.81B

Latest newsMore news →

No recent news for 476060.KQ.

Similar companies

Pharmicell Co., Ltd.005690.KS Chabiotech Co.,Ltd.085660.KQ GI Innovation, Inc.358570.KQ Medy-Tox Inc.086900.KQ Green Cross Holdings Corporation005250.KS 百济神州688235.SH Find similar companies →

Latest newsMore news →

No recent news for 476060.KQ.